IDS update proves resilience and cash generation

Revenues from medical diagnostics group Immunodiagnostic Systems to the end of March will be marginally reduced on the previous year but in line with expectations.

Revenues from medical diagnostics group Immunodiagnostic Systems to the end of March will be marginally reduced on the previous year but in line with expectations.

In a year-end trading update, the Newcastle-upon-Tyne based company said total revenues would hit £49.8m for the year to March 31st, down from £53.7m previously.

The group delivered particularly strong cashflow in the year, generating £13.6m of cash compared to a pre-exceptional £6.7m in 2012, to leave year-end net funds at £20.5m.

The company claimed the performance was encouraging in light of the tough trading environment, where its historically strong market of manual vitamin D testing is declining "rapidly", while competition increasing in automated vitamin D market too, all against a backdrop of a shrinking number of laboratory customers due to consolidation.

The average revenue per direct instrument placed with customers was £72,000 per year, falling from £84,000 in the previous period.

Looking forward, IDH declared it would continue to pursue its threefold strategy of developing new specialist assays, entering into new geographies with attractive growth opportunities and developing the next-generation IDS-iSYS system, having made progress in all three of these areas during 2012/13.

Management anticipates a number of further product launches in 2013/14, with US regulatory clearance sought for five automated assays which have already achieved European CE marking.

Patrik Dahlen, Chief Executive Officer of IDS, said: "We are pleased to report trading has been in line with Company guidance following a strong second half of the financial year, with robust growth in our range of recently launched bone, growth and hypertension panels.

"Our focus remains on the development of our IDS-iSYS automated platform through broadening the assay menu, improved instrumentation and greater geographic penetration. We believe that IDS is now well positioned to execute this strategy and drive continued change within the business."

Analyst Savvas Neophytou at broker Panmure Gordon attributed the "impressive" cash generation to the group's "better working capital management and reduced investment".

"Nonetheless, it underlies the cash generative nature of the business," he said. "With that sort of cash, it can turn itself to self-help if future acquisitions need to be funded, thus removing the risk of dilution [from potential acquisitions].

OH

Recommended

I wish I knew what a share buyback was, but I’m too embarrassed to ask
Too embarrassed to ask

I wish I knew what a share buyback was, but I’m too embarrassed to ask

A share buyback means just what it says – a company buys back its own shares. But why? And how does that benefit shareholders?
3 Aug 2021
Improve your odds of investment success with these three stocks
Share tips

Improve your odds of investment success with these three stocks

Professional investor Tom Wildgoose of the Nomura Global High Conviction Fund highlights three of his favourite stocks.
2 Aug 2021
How to profit from pampered pets beyond the pandemic
Share tips

How to profit from pampered pets beyond the pandemic

Covid-19 has greatly boosted ownership. But the market had been expanding for years, and demographic, cultural and medical trends all point to long-te…
30 Jul 2021
Share tips of the week – 30 July
Share tips

Share tips of the week – 30 July

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
30 Jul 2021

Most Popular

Why the UK's 2.5% inflation is a big deal
Inflation

Why the UK's 2.5% inflation is a big deal

After years of inflation being a financial-assets problem, it is now an “ordinary things” problem too, says Merryn Somerset Webb. But central banks st…
16 Jul 2021
The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism
Economy

The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism

Russell Napier talks to Merryn about financial repression – or "stealing money from old people slowly" – plus how Asian capitalism is taking over in t…
16 Jul 2021
Three companies that are reaping the rewards of investment
Share tips

Three companies that are reaping the rewards of investment

Professional investor Edward Wielechowski of the Odyssean Investment Trust highlights three stocks that have have invested well – and are able to deal…
19 Jul 2021